{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:10:45Z","timestamp":1778904645274,"version":"3.51.4"},"reference-count":39,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2026,5,13]]},"DOI":"10.1248\/bpb.b25-00750","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T22:09:32Z","timestamp":1778623772000},"page":"785-793","source":"Crossref","is-referenced-by-count":0,"title":["Plasma Mid-Regional Pro-adrenomedullin as a Prognostic Biomarker in Hematopoietic Stem Cell Transplant Recipients with Febrile Neutropenia"],"prefix":"10.1248","volume":"49","author":[{"given":"Motoshi","family":"Iwao","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, 1\u20131 Idaigaoka, Hasama-machi, Yufu, Oita 879\u20135593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, 1\u20131 Idaigaoka, Hasama-machi, Yufu, Oita 879\u20135593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Shiraiwa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, 1\u20131 Idaigaoka, Hasama-machi, Yufu, Oita 879\u20135593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Sueshige","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, 1\u20131 Idaigaoka, Hasama-machi, Yufu, Oita 879\u20135593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical University, 2\u2013522\u20131 Noshio, Kiyose, Tokyo 204\u20138588, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniko","family":"Takano","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oita University Hospital, 1\u20131 Idaigaoka, Hasama-machi, Yufu, Oita 879\u20135593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Tatsuta","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, 1\u20131 Idaigaoka, Hasama-machi, Yufu, Oita 879\u20135593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Ogata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Oita University Hospital, 1\u20131 Idaigaoka, Hasama-machi, Yufu, Oita 879\u20135593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, 1\u20131 Idaigaoka, Hasama-machi, Yufu, Oita 879\u20135593, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Doulatov S, Notta F, Laurenti E, Dick JE. Hematopoiesis: a human perspective. <i>Cell Stem Cell<\/i>, <b>10<\/b>, 120\u2013136 (2012).","DOI":"10.1016\/j.stem.2012.01.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Warren JT, Link DC. Clonal hematopoiesis and risk for hematologic malignancy. <i>Blood<\/i>, <b>136<\/b>, 1599\u20131605 (2020).","DOI":"10.1182\/blood.2019000991"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Copelan EA. Hematopoietic stem-cell transplantation. <i>N. Engl. J. Med.<\/i>, <b>354<\/b>, 1813\u20131826 (2006).","DOI":"10.1056\/NEJMra052638"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) DeFilipp Z, Hefazi M, Chen YB, Blazar BR. Emerging approaches to improve allogeneic hematopoietic cell transplantation outcomes for nonmalignant diseases. <i>Blood<\/i>, <b>139<\/b>, 3583\u20133593 (2022).","DOI":"10.1182\/blood.2020009014"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. <i>Clin. Infect. Dis.<\/i>, <b>52<\/b>, e56\u2013e93 (2011).","DOI":"10.1093\/cid\/cir073"},{"key":"6","unstructured":"6) Japanese Society of Medical Oncology. <i>Clinical Practice Guidelines for Febrile Neutropenia (FN)<\/i>, 2nd ed., Kanehara &amp; Co., Ltd., Tokyo, Japan, pp. 2\u20133 (2017)."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Wade JC. Viral infections in patients with hematological malignancies. <i>Hematology (Am. Soc. Hematol. Educ. Program)<\/i>, <b>2006<\/b>, 368\u2013374 (2006).","DOI":"10.1182\/asheducation-2006.1.368"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Blazar BR, Murphy WJ, Abedi M. Advances in graft-versus-host disease biology and therapy. <i>Nat. Rev. Immunol.<\/i>, <b>12<\/b>, 443\u2013458 (2012).","DOI":"10.1038\/nri3212"},{"key":"9","unstructured":"9) World Health Organization. <i>Global action plan on antimicrobial resistance<\/i>. World Health Organization, Geneva (2015)."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Dyar OJ, Huttner B, Schouten J, Pulcini C. What is antimicrobial stewardship? <i>Clin. Microbiol. Infect.<\/i>, <b>23<\/b>, 793\u2013798 (2017).","DOI":"10.1016\/j.cmi.2017.08.026"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. <i>Crit. Care Med.<\/i>, <b>34<\/b>, 1589\u20131596 (2006).","DOI":"10.1097\/01.CCM.0000217961.75225.E9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Aslan AT, Akova M, Kontoyiannis DP. The heterogeneous syndrome of noninfectious causes of persistent fever in neutropenic patients with hematologic malignancy: another opportunity for stewardship? Clin. <i>Infect. Dis.<\/i>, <b>79<\/b>, 1333\u20131337 (2024).","DOI":"10.1093\/cid\/ciae487"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, Wingard JR, Young JA, Boeckh MJ. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. <i>Biol. Blood Marrow Transplant.<\/i>, <b>15<\/b>, 1143\u20131238 (2009).","DOI":"10.1016\/j.bbmt.2009.06.019"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>192<\/b>, 553\u2013560 (1993).","DOI":"10.1006\/bbrc.1993.1451"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Struck J, Tao C, Morgenthaler NG, Bergmann A. Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. <i>Peptides<\/i>, <b>25<\/b>, 1369\u20131372 (2004).","DOI":"10.1016\/j.peptides.2004.06.019"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nishikimi T. Adrenomedullin in the kidney-renal physiological and pathophysiological roles. <i>Curr. Med. Chem.<\/i>, <b>14<\/b>, 1689\u20131699 (2007).","DOI":"10.2174\/092986707780830943"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. <i>Clin. Chem.<\/i>, <b>51<\/b>, 1823\u20131829 (2005).","DOI":"10.1373\/clinchem.2005.051110"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Baumer U, Kazem N, Hammer A, Hofer F, Steinacher E, Koller L, Zimpfer D, Andreas M, Steinlechner B, Hengstenberg C, Niessner A, Sulzgruber P. Mid-regional pro-adrenomedullin is associated with adverse cardiovascular outcomes after cardiac surgery. <i>J. Pers. Med.<\/i>, <b>15<\/b>, 47 (2025).","DOI":"10.3390\/jpm15020047"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wild PS, Schnabel RB, Lubos E, Zeller T, Sinning CR, Keller T, Tzikas S, Lackner KJ, Peetz D, Rupprecht HJ, Bickel C, Morgenthaler NG, Papassotiriou J, Tiret L, M\u00fcnzel T, Blankenberg S. Midregional proadrenomedullin for prediction of cardiovascular events in coronary artery disease: results from the AtheroGene study. <i>Clin. Chem.<\/i>, <b>58<\/b>, 226\u2013236 (2012).","DOI":"10.1373\/clinchem.2010.157842"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Artunc F, Nowak A, Mueller C, Breidthardt T, Twerenbold R, Wagner R, Peter A, Haering HU, Ebmeyer S, Friedrich B. Plasma concentrations of the vasoactive peptide fragments mid-regional pro-adrenomedullin, C-terminal pro-endothelin 1 and copeptin in hemodialysis patients: associated factors and prediction of mortality. <i>PLOS ONE<\/i>, <b>9<\/b>, e86148 (2014).","DOI":"10.1371\/journal.pone.0086148"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Iwao M, Tanaka R, Suzuki Y, Nakata T, Aoki K, Fukuda A, Fukunaga N, Tatsuta R, Ohno K, Shibata H, Itoh H. Association between MR-proADM concentration and treatment intensity of antihypertensive agents in chronic kidney disease patients with insufficient blood pressure control. <i>Sci. Rep.<\/i>, <b>11<\/b>, 21931 (2021).","DOI":"10.1038\/s41598-021-01403-2"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Bello S, Lasierra AB, Minchol\u00e9 E, Fandos S, Ruiz MA, Vera E, de Pablo F, Ferrer M, Menendez R, Torres A. Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. <i>Eur. Respir. J.<\/i>, <b>39<\/b>, 1144\u20131155 (2012).","DOI":"10.1183\/09031936.00080411"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Liu D, Xie L, Zhao H, Liu X, Cao J. Prognostic value of mid-regional pro-adrenomedullin (MR-proADM) in patients with community-acquired pneumonia: a systematic review and meta-analysis. <i>BMC Infect. Dis.<\/i>, <b>16<\/b>, 232 (2016).","DOI":"10.1186\/s12879-016-1566-3"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Spoto S, Basili S, Cangemi R, D\u2019Avanzo G, Lupoi DM, Romiti GF, Argemi J, Yuste JR, Lucena F, Locorriere L, Masini F, Testorio G, Calarco R, Fogolari M, Francesconi M, Battifoglia G, Costantino S, Angeletti S. Mid-regional pro-adrenomedullin can predict organ failure and prognosis in sepsis? <i>Int. J. Mol. Sci.<\/i>, <b>24<\/b>, 17429 (2023).","DOI":"10.3390\/ijms242417429"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Valeriani E, Falletta A, Pastori D, Porfidia A, Mastroianni CM, Di Bari S, Motta E, Pignatelli P, Oliva A. Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis. <i>Eur. J. Clin. Invest.<\/i>, <b>54<\/b>, e14225 (2024).","DOI":"10.1111\/eci.14225"},{"key":"26","unstructured":"26) Al Shuaibi M, Bahu RR, Chaftari AM, Al Wohoush I, Shomali W, Jiang Y, Debiane L, Raad S, Jabbour J, Al Akhrass F, Hachem RY, Raad I. Pro-adrenomedullin as a novel biomarker for predicting infections and response to antimicrobials in febrile patients with hematologic malignancies. <i>Clin. Infect. Dis.<\/i>, <b>56<\/b>, 943\u2013950 (2013)."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. <i>Clin. Chem.<\/i>, <b>51<\/b>, 1823\u20131829 (2005).","DOI":"10.1373\/clinchem.2005.051110"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Iwao M, Suzuki Y, Tanaka R, Koyama T, Ozaki E, Nakata T, Aoki K, Fukuda A, Sato Y, Kuriyama N, Fukunaga N, Sato F, Katagiri F, Ohno K, Shibata H, Mimata H, Itoh H. Sensitive and selective quantification of mid-regional proadrenomedullin in human plasma using ultra-performance liquid chromatography coupled with tandem mass spectrometry. <i>J. Pharm. Biomed. Anal.<\/i>, <b>183<\/b>, 113168 (2020).","DOI":"10.1016\/j.jpba.2020.113168"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Harris AC, Young R, Devine S, <i>et al<\/i>. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium. <i>Biol. Blood Marrow Transplant.<\/i>, <b>22<\/b>, 4\u201310 (2016).","DOI":"10.1016\/j.bbmt.2015.09.001"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Suzuki Y, Koyama T, Negami J, Toyama D, Oda A, Tanaka R, Iwao M, Tatsuta R, Ando T, Shin T, Itoh H, Ohno K. Ultra-sensitive quantification of mid-regional proadrenomedullin in human plasma using micro-liquid chromatography coupled to quadrupole time-of-flight mass spectrometry. <i>ACS Omega<\/i>, <b>10<\/b>, 24214\u201324223 (2025).","DOI":"10.1021\/acsomega.4c11248"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Legramante JM, Mastropasqua M, Susi B, Porzio O, Mazza M, Miranda Agrippino G, D Agostini C, Brandi A, Giovagnoli G, Di Lecce VN, Bernardini S, Minieri M. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB. <i>PLOS ONE<\/i>, <b>12<\/b>, e0187702 (2017).","DOI":"10.1371\/journal.pone.0187702"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Christ-Crain M, Morgenthaler NG, Stolz D, M\u00fcller C, Bingisser R, Harbarth S, Tamm M, Struck J, Bergmann A, M\u00fcller B. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia. <i>Crit. Care<\/i>, <b>10<\/b>, R96 (2006).","DOI":"10.1186\/cc4955"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Valeriani E, Falletta A, Pastori D, Porfidia A, Mastroianni CM, Di Bari S, Motta E, Pignatelli P, Oliva A. Midregional-proAdrenomedullin as a prognostic tool in sepsis and septic shock: A systematic review and meta-analysis. <i>Eur. J. Clin. Invest.<\/i>, <b>54<\/b>, e14225 (2024).","DOI":"10.1111\/eci.14225"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Baumann P, Fuchs A, Gotta V, Ritz N, Baer G, Bonhoeffer JM, Buettcher M, Heininger U, Szinnai G, Bonhoeffer J. The kinetic profiles of copeptin and mid regional proadrenomedullin (MR-proADM) in pediatric lower respiratory tract infections. <i>PLOS ONE<\/i>, <b>17<\/b>, e0264305 (2022).","DOI":"10.1371\/journal.pone.0264305"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Gille J, Ostermann H, Dragu A, Sablotzki A. MR-proADM: a new biomarker for early diagnosis of sepsis in burned patients. <i>J. Burn Care Res.<\/i>, <b>38<\/b>, 290\u2013298 (2017).","DOI":"10.1097\/BCR.0000000000000508"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Liang J, Cai Y, Shao Y. Comparison of presepsin and Mid-regional pro-adrenomedullin in the diagnosis of sepsis or septic shock: a systematic review and meta-analysis. <i>BMC Infect. Dis.<\/i>, <b>23<\/b>, 288 (2023).","DOI":"10.1186\/s12879-023-08262-4"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Enguix-Armada A, Escobar-Conesa R, Garc\u00eda-De La Torre A, De La Torre-Prados MV. Usefulness of several biomarkers in the management of septic patients: C-reactive protein, procalcitonin, presepsin and mid-regional pro-adrenomedullin. <i>Clin. Chem. Lab. Med.<\/i>, <b>54<\/b>, 163\u2013168 (2016).","DOI":"10.1515\/cclm-2015-0243"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) D\u00f6hner H, Estey E, Grimwade D, <i>et al<\/i>. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. <i>Blood<\/i>, <b>129<\/b>, 424\u2013447 (2017).","DOI":"10.1182\/blood-2016-08-733196"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Benamu E, Gajurel K, Anderson JN, Lieb T, Gomez CA, Seng H, Aquino R, Hollemon D, Hong DK, Blauwkamp TA, Kertesz M, Blair L, Bollyky PL, Medeiros BC, Coutre S, Zompi S, Montoya JG, Deresinski S. Plasma microbial cell-free DNA next-generation sequencing in the diagnosis and management of febrile neutropenia. <i>Clin. Infect. Dis.<\/i>, <b>74<\/b>, 1659\u20131668 (2022).","DOI":"10.1093\/cid\/ciab324"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/5\/49_b25-00750\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T03:26:19Z","timestamp":1778901979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/49\/5\/49_b25-00750\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b25-00750","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"b25-00750"}}